NewsBenzingaScotiabank mantiene su recomendación de superar al sector para Eli Lilly y eleva el precio objetivo a 1605 dólares Scotiabank mantiene su recomendación de superar al sector para Eli Lilly y eleva el precio objetivo a 1605 dólares Benzinga 2026.10.30 18:56 (GMT+0) Open on Benzinga Other news Here’s How Much You Would Have Made Owning Elbit Systems Stock In The Last 5 Years Citigroup Maintains Neutral on Enphase Energy, Lowers Price Target to $25 Anthropic Could Join Public Markets With a Junk Rating Despite $112B Cash Pile, Blackstone Warns Citigroup Maintains Buy on Alphabet, Lowers Price Target to $375 Meta Platforms Outlook Revised To Negative On Significant Uncertainty Around Capex And Free Operating Cash Flow Citigroup Maintains Buy on Antero Resources, Raises Price Target to $50
Meta Platforms Outlook Revised To Negative On Significant Uncertainty Around Capex And Free Operating Cash Flow
